BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30880401)

  • 1. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
    Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Communication: Carotid Intima-Media Thickness Is Not Associated with Neurocognitive Impairment Among People Older than 50 Years With and Without HIV Infection from Thailand.
    Hiransuthikul A; Chutinet A; Sakulrak S; Samajarn J; Vongsayan P; Kijpaisalratana N; Akarathanawat W; Apornpong T; Sangarlangkarn A; Gatechompol S; Han WM; Chattranukulchai P; Kerr S; Ruxrungtham K; Avihingsanon A
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1170-1173. PubMed ID: 31588776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
    Métral M; Darling K; Locatelli I; Nadin I; Santos G; Brugger P; Kovari H; Cusini A; Gutbrod K; Tarr PE; Calmy A; Lecompte TD; Assal F; Monsch A; Kunze U; Stoeckle M; Schwind M; Schmid P; Pignatti R; Di Benedetto C; Du Pasquier R; Cavassini M; ;
    HIV Med; 2020 Jan; 21(1):30-42. PubMed ID: 31589807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.
    Bharti AR; McCutchan A; Deutsch R; Smith DM; Ellis RJ; Cherner M; Woods SP; Heaton RK; Grant I; Letendre SL
    Clin Infect Dis; 2016 Dec; 63(12):1655-1660. PubMed ID: 27794019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
    Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
    Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohort.
    Lin H; Ding Y; Ning C; Qiao X; Chen X; Chen X; Shen W; Liu X; Hong Y; He N
    Lancet HIV; 2019 Dec; 6(12):e860-e868. PubMed ID: 31635991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.
    Kalayjian RC; Robertson KR; Albert JM; Fichtenbaum CJ; Brown TT; Taiwo BO;
    J Acquir Immune Defic Syndr; 2019 Jun; 81(2):e49-e54. PubMed ID: 30939531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
    Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M;
    Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
    Nyundo AA
    PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.
    Saloner R; Grelotti DJ; Tyree G; Sundermann EE; Ma Q; Letendre S; Heaton RK; Cherner M
    J Acquir Immune Defic Syndr; 2019 Dec; 82(5):475-482. PubMed ID: 31714426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Steatosis to Neurocognitive Function in People Living with HIV.
    Marić D; Brkić S; Ignjatović VB; Nikolaševic Ž; Ilić D; Vujanović M; Drvendžija Z; Galić BS
    Curr HIV Res; 2020; 18(3):172-180. PubMed ID: 32106801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
    Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
    AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical atherosclerosis in low Framingham risk HIV patients.
    León R; Reus S; López N; Portilla I; Sánchez-Payá J; Giner L; Boix V; Merino E; Torrús D; Moreno-Pérez Ó; Portilla J
    Eur J Clin Invest; 2017 Aug; 47(8):591-599. PubMed ID: 28664622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
    Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
    Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.
    Robertson KR; Jiang H; Kumwenda J; Supparatpinyo K; Marra CM; Berzins B; Hakim J; Sacktor N; Campbell TB; Schouten J; Mollan K; Tripathy S; Kumarasamy N; La Rosa A; Santos B; Silva MT; Kanyama C; Firhnhaber C; Murphy R; Hall C; Marcus C; Naini L; Masih R; Hosseinipour MC; Mngqibisa R; Badal-Faesen S; Yosief S; Vecchio A; Nair A;
    Clin Infect Dis; 2019 May; 68(10):1733-1738. PubMed ID: 30219843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Mental Health Conditions in the Diagnosis of Neurocognitive Impairment in People Living with HIV.
    Portilla-Tamarit I; Ruiz-Robledillo N; Díez-Martínez M; Ferrer-Cascales R; Alcocer-Bruno C; Portilla J
    Diagnostics (Basel); 2020 Jul; 10(8):. PubMed ID: 32751759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis.
    Habib AG; Yakasai AM; Owolabi LF; Ibrahim A; Habib ZG; Gudaji M; Karaye KM; Ibrahim DA; Nashabaru I
    Int J Infect Dis; 2013 Oct; 17(10):e820-31. PubMed ID: 23953699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive Disorders in HIV-positive Patients.
    Padole PS; Padhiyar RN; Yadav DS; Chavan SA
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.